- Home
- APLT vs PZG Comparison
APLT vs PZG Comparison
Compare APLT & PZG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- PZG
- Stock Information
- Founded
- APLT 2016
- PZG 1992
- Country
- APLT United States
- PZG United States
- Employees
- APLT N/A
- PZG N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- PZG Metal Mining
- Sector
- APLT Health Care
- PZG Basic Materials
- Exchange
- APLT Nasdaq
- PZG Nasdaq
- Market Cap
- APLT 37.5M
- PZG 41.2M
- IPO Year
- APLT 2019
- PZG 1999
- Fundamental
- Price
- APLT $0.35
- PZG $0.61
- Analyst Decision
- APLT Buy
- PZG
- Analyst Count
- APLT 7
- PZG 0
- Target Price
- APLT $6.10
- PZG N/A
- AVG Volume (30 Days)
- APLT 1.4M
- PZG 479.5K
- Earning Date
- APLT 08-06-2025
- PZG 05-12-2025
- Dividend Yield
- APLT N/A
- PZG N/A
- EPS Growth
- APLT N/A
- PZG N/A
- EPS
- APLT N/A
- PZG N/A
- Revenue
- APLT $265,000.00
- PZG N/A
- Revenue This Year
- APLT $1,768.13
- PZG N/A
- Revenue Next Year
- APLT $292.85
- PZG N/A
- P/E Ratio
- APLT N/A
- PZG N/A
- Revenue Growth
- APLT N/A
- PZG N/A
- 52 Week Low
- APLT $0.30
- PZG $0.31
- 52 Week High
- APLT $10.62
- PZG $0.65
- Technical
- Relative Strength Index (RSI)
- APLT 42.17
- PZG 65.57
- Support Level
- APLT $0.34
- PZG $0.60
- Resistance Level
- APLT $0.38
- PZG $0.65
- Average True Range (ATR)
- APLT 0.02
- PZG 0.04
- MACD
- APLT -0.00
- PZG -0.00
- Stochastic Oscillator
- APLT 7.14
- PZG 60.73
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About PZG Paramount Gold Nevada Corp.
Paramount Gold Nevada Corp is an exploration-stage mining company. Together with its subsidiaries, the company is engaged in the business of acquiring, exploring, and developing precious metal projects in the United States. Also, it explores for gold and silver. The company enhances the value of projects by implementing exploration and engineering programs that are likely to expand and upgrade known mineralized material to reserves. Its projects include sleeper gold, grassy mountain gold, frost project, other non-material, and others.